JP2011514335A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011514335A5 JP2011514335A5 JP2010547641A JP2010547641A JP2011514335A5 JP 2011514335 A5 JP2011514335 A5 JP 2011514335A5 JP 2010547641 A JP2010547641 A JP 2010547641A JP 2010547641 A JP2010547641 A JP 2010547641A JP 2011514335 A5 JP2011514335 A5 JP 2011514335A5
- Authority
- JP
- Japan
- Prior art keywords
- receptor complex
- partially
- heteromeric receptor
- csf
- antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6653808P | 2008-02-21 | 2008-02-21 | |
| US14590109P | 2009-01-20 | 2009-01-20 | |
| PCT/US2009/001085 WO2009136976A2 (en) | 2008-02-21 | 2009-02-20 | Il-17ra-il-17rb antagonists and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014025504A Division JP2014122231A (ja) | 2008-02-21 | 2014-02-13 | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011514335A JP2011514335A (ja) | 2011-05-06 |
| JP2011514335A5 true JP2011514335A5 (https=) | 2012-04-05 |
Family
ID=41265206
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010547641A Pending JP2011514335A (ja) | 2008-02-21 | 2009-02-20 | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
| JP2014025504A Withdrawn JP2014122231A (ja) | 2008-02-21 | 2014-02-13 | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
| JP2014115952A Active JP5647748B2 (ja) | 2008-02-21 | 2014-06-04 | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014025504A Withdrawn JP2014122231A (ja) | 2008-02-21 | 2014-02-13 | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
| JP2014115952A Active JP5647748B2 (ja) | 2008-02-21 | 2014-06-04 | Ｉｌ−１７ｒａ−ｉｌ−１７ｒｂアンタゴニストおよび該アンタゴニストの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20110052600A1 (https=) |
| EP (1) | EP2250200A2 (https=) |
| JP (3) | JP2011514335A (https=) |
| KR (1) | KR101240904B1 (https=) |
| CN (2) | CN102037017B (https=) |
| AU (2) | AU2009244878B2 (https=) |
| BR (1) | BRPI0907196B1 (https=) |
| CA (1) | CA2715503C (https=) |
| MX (1) | MX2010009100A (https=) |
| MY (1) | MY184345A (https=) |
| WO (1) | WO2009136976A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| GB0905972D0 (en) | 2009-04-06 | 2009-05-20 | Medical Res Council | Antibodies against IL-17BR |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| HUE036157T2 (hu) | 2010-03-30 | 2018-06-28 | Janssen Biotech Inc | Humanizált IL-25 ellenanyagok |
| MX360946B (es) * | 2010-09-22 | 2018-10-29 | Amgen Inc Star | Inmunoglobulinas portadoras y usos de las mismas. |
| CN102188707B (zh) * | 2011-02-25 | 2015-08-05 | 中国医学科学院基础医学研究所 | Il-17抑制剂在制备治疗流感的药物中的用途 |
| WO2013016220A1 (en) * | 2011-07-22 | 2013-01-31 | Amgen Inc. | Il-17 receptor a is required for il-17c biology |
| JP2015521591A (ja) * | 2012-06-12 | 2015-07-30 | オレガ・バイオテック | Ｉｌ−１７アイソフォームのアンタゴニストおよびその使用 |
| US9757529B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| US9757395B2 (en) | 2012-12-20 | 2017-09-12 | Otitopic Inc. | Dry powder inhaler and methods of use |
| AU2013388034B2 (en) | 2013-04-30 | 2019-08-15 | Aspeya US Inc. | Dry powder formulations and methods of use |
| US9858304B2 (en) * | 2014-04-15 | 2018-01-02 | Raytheon Company | Computing cross-correlations for sparse data |
| WO2016070062A2 (en) * | 2014-10-31 | 2016-05-06 | Genentech, Inc. | Anti-il-17a and il-17f cross reactive antibody variants and compositions comprising and methods of making and using same |
| WO2018018082A1 (en) | 2016-07-26 | 2018-02-01 | The Australian National University | Immunostimulatory compositions and uses therefor |
| CN106729634A (zh) * | 2017-01-05 | 2017-05-31 | 中国科学院微生物研究所 | 白介素17在抵御流感病毒侵染中的应用 |
| JP7493449B2 (ja) | 2017-09-22 | 2024-05-31 | ヴェクチュラ インコーポレイテッド | ステアリン酸マグネシウムを含む乾燥粉末組成物 |
| US10786456B2 (en) | 2017-09-22 | 2020-09-29 | Otitopic Inc. | Inhaled aspirin and magnesium to treat inflammation |
| WO2022132705A1 (en) * | 2020-12-14 | 2022-06-23 | Academia Sinica | Antagonist of interleukin-17b receptor (il-17rb) and use thereof |
| TWI811957B (zh) * | 2021-01-14 | 2023-08-11 | 中央研究院 | 重組多肽，包含該重組多肽的複合物，以及其用途 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ306653A (en) * | 1995-03-23 | 1999-03-29 | Immunex Corp | Isolated dna il-17 receptors |
| US6680057B1 (en) * | 1995-03-23 | 2004-01-20 | Immunex Corporation | Methods of treating autoimmune disease by administering interleukin-17 receptor |
| US6849719B2 (en) * | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
| ES2333385T3 (es) * | 1997-09-17 | 2010-02-19 | Human Genome Sciences, Inc. | Proteina del tipo de interleuquina-17. |
| US6482923B1 (en) * | 1997-09-17 | 2002-11-19 | Human Genome Sciences, Inc. | Interleukin 17-like receptor protein |
| US20030180255A1 (en) * | 2000-08-24 | 2003-09-25 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| CA2425506A1 (en) * | 2000-10-18 | 2002-08-01 | Immunex Corporation | Methods for treating rheumatoid arthritis using il-17 antagonists |
| CN101160528A (zh) * | 2005-02-14 | 2008-04-09 | 惠氏公司 | Il17-f在诊断和治疗气道炎症中的用途 |
| US20080199460A1 (en) | 2005-09-01 | 2008-08-21 | Schering Corporation | Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease |
| US7767206B2 (en) * | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
| AU2008266948B2 (en) * | 2007-06-13 | 2012-08-23 | Kirin-Amgen, Inc. | IL-17 heteromeric receptor complex |
| JP5561689B2 (ja) * | 2007-11-28 | 2014-07-30 | 独立行政法人理化学研究所 | Ｉｌ−１７ｒｂ陽性ｎｋｔ細胞を用いたアレルギー性気道炎症及び／又は気道過敏症の治療薬のスクリーニング方法 |
-
2009
- 2009-02-20 WO PCT/US2009/001085 patent/WO2009136976A2/en not_active Ceased
- 2009-02-20 MY MYPI2010003877A patent/MY184345A/en unknown
- 2009-02-20 CN CN200980115731.8A patent/CN102037017B/zh active Active
- 2009-02-20 MX MX2010009100A patent/MX2010009100A/es active IP Right Grant
- 2009-02-20 AU AU2009244878A patent/AU2009244878B2/en active Active
- 2009-02-20 EP EP09742963A patent/EP2250200A2/en not_active Withdrawn
- 2009-02-20 CA CA2715503A patent/CA2715503C/en active Active
- 2009-02-20 JP JP2010547641A patent/JP2011514335A/ja active Pending
- 2009-02-20 CN CN201410242489.3A patent/CN104151428B/zh active Active
- 2009-02-20 US US12/918,449 patent/US20110052600A1/en not_active Abandoned
- 2009-02-20 KR KR1020107021168A patent/KR101240904B1/ko active Active
- 2009-02-20 BR BRPI0907196-2A patent/BRPI0907196B1/pt active IP Right Grant
-
2013
- 2013-05-16 AU AU2013205944A patent/AU2013205944A1/en not_active Abandoned
-
2014
- 2014-02-13 JP JP2014025504A patent/JP2014122231A/ja not_active Withdrawn
- 2014-04-28 US US14/263,534 patent/US20140322238A1/en not_active Abandoned
- 2014-06-04 JP JP2014115952A patent/JP5647748B2/ja active Active
-
2016
- 2016-01-12 US US14/994,108 patent/US20160208004A1/en not_active Abandoned
- 2016-11-02 US US15/341,870 patent/US20170114140A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011514335A5 (https=) | ||
| CA2715503A1 (en) | Il-17ra-il-17rb antagonists and uses thereof | |
| JP2021531022A5 (https=) | ||
| JP2012500004A5 (https=) | ||
| JP2010535786A5 (https=) | ||
| JP2007514637A5 (https=) | ||
| JP2005501550A5 (https=) | ||
| JP2012502037A5 (https=) | ||
| JP2014506321A5 (https=) | ||
| JP2017509354A5 (https=) | ||
| JP2011092201A5 (https=) | ||
| JP2012029693A5 (https=) | ||
| JP2012105686A5 (https=) | ||
| JP2011184466A5 (https=) | ||
| JP2008533007A5 (https=) | ||
| DK2155866T3 (da) | Modificerede phosphataser | |
| JP2013079285A5 (https=) | ||
| JP2010500343A5 (https=) | ||
| JP2010520911A5 (https=) | ||
| JP2013510169A5 (https=) | ||
| JP2013533268A5 (https=) | ||
| JP2012512814A5 (https=) | ||
| CN115605475A (zh) | 一种免疫抑制剂、其制备方法和应用 | |
| JP2014504865A5 (https=) | ||
| JP2008501316A5 (https=) |